医疗事故不可避免,但生命的珍贵足以让人们去重新考虑基因疗法的可行性36岁的莫尔患有风湿性关节炎,今年7月,她决定接受基因疗法,试剂注射到她的右膝之后引发急性感染,导致器官功能丧失而死亡。莫尔的死亡将对病人进行风险性实验疗法的伦理道德的讨论再次推到台前,特别是对那些没有重大生命危险、使用其他手段尚能控制病情的病人。 Medical Incident is inevitable, but life is precious enough for people to reconsider the feasibility of gene therapy. 36-year-old Moore suffered from rheumatoid arthritis. In July of this year, she decided to undergo gene therapy. After the injection of the agent into her right knee, Induces an acute infection, resulting in loss of organ function and death. Moore’s death will once again push the ethical discussion of the patient’s risky experimental therapies to the stage, especially for those patients who have no major life-threatening and who can use other means to control their condition.